Clinical Trials Browser

Phase 2 × Neoplasms × tislelizumab × Clear all

NCT04363801 2025-10-09

DisTinGuish

Phase 2 Terminated

247 enrolled 38 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT04985721 2023-03-15

IMPARP-HRD

Phase 2 Unknown

Neoplasms

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Phase 2 Unknown

Neoplasms